Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Glaucoma Drainage Devices Market Poised To Hit $1.42 Billion By 2030 With A 9.7% CAGR#_x000D_
The glaucoma drainage devices market size has experienced robust growth in recent years. It is anticipated to expand from $0.89 billion in 2025 to $0.98 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.0%. This historical expansion can be attributed to factors such as the increasing prevalence of glaucoma, the expansion of ophthalmic surgical centers, the growing adoption of surgical glaucoma treatments, a rising aging population, and the greater availability of specialized eye care facilities._x000D_
_x000D_
The glaucoma drainage devices market size is anticipated to experience robust expansion over the next few years. It is projected to reach $1.42 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. This growth during the forecast period is attributable to the increasing demand for minimally invasive eye surgeries, rising investments in ophthalmic device innovation, the expansion of advanced glaucoma care programs, a growing focus on early intervention, and technological advancements in implant materials and design. Major trends foreseen in this period include the increasing adoption of minimally invasive glaucoma implants, a rising demand for valved drainage devices, an enhanced focus on long-term intraocular pressure control, the broadening use of advanced biocompatible materials, and greater precision in surgical implant design._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Glaucoma Drainage Devices Market Opportunity Drivers: What’s Unlocking New Revenue Potential?#_x000D_
The growing incidence of glaucoma conditions is anticipated to stimulate the expansion of the glaucoma drainage devices market. Glaucoma refers to a collection of eye ailments that harm the optic nerve, often stemming from elevated intraocular pressure, which can lead to permanent vision loss if untreated. The rise in glaucoma cases is linked to factors such as an aging demographic, increased urbanization, and evolving lifestyle patterns. Glaucoma drainage devices offer a solution for managing intraocular pressure in refractory glaucoma by aiding the outflow of aqueous humor when standard therapies prove ineffective. As an illustration, The NHS Confederation, a UK-based membership organization, indicated in October 2025 that glaucoma, which is the primary cause of irreversible blindness in the UK, impacts more than 700,000 individuals. Almost half of these individuals remain undiagnosed due to the lack of symptoms and prolonged hospital wait times. NHS waiting periods can extend up to 72 weeks, and a 25% increase in significant eye conditions is expected between 2022–2032, far exceeding population growth by seven times. Thus, the escalating prevalence of glaucoma conditions is a key driver for the glaucoma drainage devices market. The future growth of the glaucoma drainage devices market is anticipated to be boosted by the ongoing expansion in healthcare infrastructure. This infrastructure encompasses the entire network of medical facilities, including hospitals, clinics, and diagnostic centers, which ensures access to quality healthcare services for people. Growth in healthcare infrastructure is fueled by rising government and private investments, population increases, and a greater need for advanced medical treatments. Better infrastructure facilitates the adoption of innovative medical technologies, enhances patient accessibility to care, and improves the overall efficiency of healthcare provision. For example, a report released in May 2023 by the Office for National Statistics, a UK government department, revealed that healthcare spending in the UK rose by 5.6% between 2022 and 2023, a significant increase compared to the 0.9% growth observed in 2022. The total UK healthcare expenditure was approximately $317.63 billion (£292 billion) in 2023. Consequently, the development of healthcare infrastructure is a significant factor propelling the glaucoma drainage devices market forward._x000D_
_x000D_
#Glaucoma Drainage Devices Market Segment Landscape And Growth Outlook#_x000D_
The glaucoma drainage devices market covered in this report is segmented – _x000D_
_x000D_
1) By Product Type: Valved Glaucoma Drainage Devices, Non-Valved Glaucoma Drainage Devices_x000D_
2) By Surgery Type: Conventional Glaucoma Surgery, Minimally Invasive Glaucoma Surgery_x000D_
3) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Valved Glaucoma Drainage Devices: Ahmed Glaucoma Valve, Baerveldt Glaucoma Implant, Krupin Implant, Others _x000D_
2) By Non-Valved Glaucoma Drainage Devices: Molteno Implant, Schocket Implant, Foster Implant, Others _x000D_
_x000D_
_x000D_
#Glaucoma Drainage Devices Market Innovation Trends Shaping Future Development#_x000D_
Major companies operating in the glaucoma drainage devices market are concentrating on developing next-generation canal-based glaucoma surgery devices. This effort aims to offer minimally invasive options and respond to the growing need for safer, more efficient treatments. Canal-based glaucoma surgery devices are implants specifically designed to target the Schlemm’s canal, thereby enhancing aqueous humor drainage and reducing intraocular pressure (IOP). This mechanism assists in managing glaucoma by addressing the primary cause of the condition’s progression. For instance, in March 2023, Nova Eye Medical Limited, an Australia-based glaucoma devices manufacturer, received clearance for its iTrack Advance canaloplasty device. This innovative device is engineered for microcatheterization and viscodilation, intended to reduce intraocular pressure (IOP) in adult patients with primary open-angle glaucoma. The iTrack Advance is equipped with an ergonomic handpiece and enhanced technology to improve surgical efficiency. It is designed for both standalone procedures and those performed in conjunction with cataract surgery._x000D_
_x000D_
#Glaucoma Drainage Devices Market Company Landscape And Competitive Strategy#_x000D_
Major companies operating in the glaucoma drainage devices market are AbbVie Inc., Alcon Inc., Johnson And Johnson Vision Care Inc., Santen Pharmaceutical Co. Ltd., Glaukos Corporation, Ocular Therapeutix Inc., IRIDEX Corporation, New World Medical Inc., Ivantis Inc., iSTAR Medical, Nova Eye Medical Limited, Altomed, Aurolab, G.surgiwear Limited, Eagle Vision Inc., Advanced Ophthalmic Innovations Pte Ltd., Avisi Technologies Inc., iVeena Delivery Systems, Optonol Ltd., Rheon-medical _x000D_
_x000D_
#View The Full Glaucoma Drainage Devices Market Report:#_x000D_
_x000D_
#Glaucoma Drainage Devices Market Largest Region: Which Geography Holds The Biggest Share?#_x000D_
North America was the largest region in the glaucoma drainage devices market in 2025. The regions covered in the glaucoma drainage devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
